プレシジョンクリニック東京, located in the heart of Ginza, Tokyo, is a medical clinic specializing in medical oncology. The clinic's guiding concept of "precision medicine" is a next-generation cancer treatment that combines immunotherapy and chemotherapy based on each patient's genomic information, aiming for a cure even in stage 4 advanced cancer. Since its founding in 2005, the group has accumulated over 6,000 treatment cases and has published numerous academic papers on its core immunotherapy technology, dendritic cell vaccine therapy, both domestically and internationally. It also achieved a world first by launching a clinical trial for pancreatic cancer treatment in Japan. The medical team comprises specialists in immunotherapy, chemotherapy, nutritional therapy, and research and development, and includes a certified cancer pharmacotherapy specialist accredited by the Japan Society of Clinical Oncology. Another distinguishing feature of the clinic is that it accepts patients in a wide range of circumstances, including those who have been given a terminal prognosis, those who have exhausted standard treatment options, and those seeking relapse prevention. Consulting hours are from 10:00 to 18:00 on weekdays and Saturdays. The clinic is fully barrier-free and accepts credit cards and electronic payments.